Latest news with #NickJames
RNZ News
15-07-2025
- RNZ News
Police investigate death on railway line, Hutt Valley services still disrupted
Emergency tape blocked the entrances to Lower Hutt's Waterloo Station on Tuesday afternoon. Photo: RNZ / Nick James Hutt Valley train services are still disrupted after a person died on the railway tracks at Waterloo Station . Police are investigating and said officers were providing support to the family. Train services were suspended between Petone and Upper Hutt on Tuesday. On Wednesday morning, the Hutt Valley line was running with reduced capacity affecting several stops. Buses also replaced trains for some Wairarapa line services, or were operating with reduced capacity.
RNZ News
07-07-2025
- Climate
- RNZ News
Cleanup continues for flood damaged Tasman residents
The rain may have stopped but the cleanup continues for residents of the Tasman town of Wakefield, which was badly hit in the recent floods. Officials say the region is currently transitioning from a state of emergency and into recovery mode a task residents are warned will be long and hard. Nick James reports. To embed this content on your own webpage, cut and paste the following: See terms of use.
RNZ News
30-06-2025
- Climate
- RNZ News
Motueka Valley bracing for more floods while still in recovery
After a weekend of major flooding, Motueka Valley residents are already being warned to brace for yet another potential deluge later this week. The area has been one of the hardest hit by flooding after the Motueka River burst its banks amid torrential rain on Friday and into Saturday. Nick James reports. To embed this content on your own webpage, cut and paste the following: See terms of use.
RNZ News
30-06-2025
- Climate
- RNZ News
Clean up underway in Nelson, Tasman after devastating floods
Farmers in Tasman and Nelson are getting on with repairs while they wait to see if more bad weather comes to frutition. RNZ reporter Nick James has been speaking to people in the region and gave an update to Charlotte Cook. To embed this content on your own webpage, cut and paste the following: See terms of use.
BBC News
24-06-2025
- Health
- BBC News
Low aspirin dose 'reduces cancer risk in some patients', Newcastle University-led study says
A study to find the right dose of aspirin to reduce the risk of cancer in some patients has found the smallest amount works just as well as larger ones, according to a leading trial involved 1,879 people with Lynch syndrome who were given three different-sized doses of the Sir John Burn, from Newcastle University, said he would ask health regulators to formally advise a low dose of 75mg be prescribed to those with the genetic condition, which puts them at a greater cancer James, who has Lynch syndrome - and who has lost nearly all of his family to cancer - was the first person to sign up to the trial. He said the findings were "massively reassuring". The furniture maker, based in Newcastle, no longer has any family left alive in the UK."Quite a few members of my family have had cancer - like colorectal cancers, or endometrial," he explained."My grandfather had bladder cancer, my mum had a certain kind of cancer. When you start looking at the family tree - it becomes quite apparent what's going on. "We didn't actually know it was Lynch syndrome until 13 years ago, and that's when I learned about the aspirin trials." To try and stop himself from developing cancer, Mr James was the first person to sign up to the latest trial nearly 10 years Cancer Prevention Project 3 study (CaPP3), supported by Cancer Research UK, involved patients taking a different daily dose of aspirin: 100mg, 300mg or 600mg. In the trial, a European-sized dose of 100 mg aspirin was used. The established dose is 75mg per day in the UK, and 81mg in the was only at the end of the study that Mr James learned he had been put on a 300mg dose."The fact that I can now go down to a baby aspirin makes it feel less scary," he said. "I didn't have any major side effects - but it potentially reduces any."That the research has shown that taking an aspirin reduces your risk of getting a cancer if you have Lynch syndrome is massively reassuring for me - and my family." Optimal dose People with Lynch syndrome have inherited a faulty gene which can increase their chances of developing some cancers - including bowel and womb Burn, who was involved in discovering Lynch syndrome and who led the international study, said he focused his research on those patients "because they get so many cancers". "We already have NICE guidance saying people with Lynch syndrome should be recommended to take aspirin. Now we should recommend a baby aspirin." An earlier study led by Prof Burn found a protective effect in those taking 600mg of aspirin every day for just over two said the new results showed the lowest dose worked just as well as the larger doses."So what we can now say with statistical confidence is that the people taking a baby aspirin are as protected as the people taking two aspirins - but also much less likely to have side effects," he added. In some people, aspirin can cause bleeding, so Prof Burn said he wanted health regulators to now recommend the lowest dose be given to Lynch syndrome patients."Roughly speaking, if someone with Lynch syndrome has about a 2% a year chance of getting mostly bowel cancers, we think if they take aspirin, that is halved - down to about 1% a year," he explained. Prof Burn said the next big challenge was to find those who were unaware they even have Lynch said "about 150,000 patients in the UK" have the condition, but a small number are only tested when they realise cancer runs in their family."It was only when they get cancer in their 40s and 50s, and remember their auntie had cancer, and their granddad." NHS England said with only 5-10% of patients diagnosed, identifying more people with Lynch syndrome was a strategic priority. Once diagnosed, they can then be offered cancer screening and monitoring. Prof Burn said: "We can also put them on to a baby aspirin - and cut their risk." The findings of the study will be presented at the Cancer Prevention Research Conference, taking place in London from Wednesday, in partnership with the American Cancer Society. Follow BBC North East on X, Facebook, Nextdoor and Instagram.
